Trial site
New York Oncology Hematology, P.C.
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Kidney cancer3 trials
- Lung cancer3 trials
- Bladder cancer2 trials
- Hodgkin lymphoma2 trials
- Metastatic breast cancer2 trials
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Head and neck cancer1 trial
- Melanoma1 trial
- Multiple myeloma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 26 trials
- Phase 34 trials
- Phase 1/22 trials
- Phase 2/32 trials
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Completed3 trials
- Terminated3 trials
- Lead sponsor
- US Oncology Research4 trials
- Hoffmann-La Roche3 trials
- Pfizer2 trials
- Astellas Pharma Global Development, Inc.1 trial
- Celgene1 trial
- and 5 more
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Recruiting
Recruiting
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Recruiting
Active, not recruiting
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Active, not recruiting
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Terminated
Completed
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Terminated
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Site data: ClinicalTrials.govUpdated 18 Nov 2026